This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2018 Apr;30(4):490-491.

doi: 10.1097/MEG.0000000000001077.

Second-line immunosuppressants for autoimmune hepatitis

Cumali Efe¹, Ersan Ozaslan², Tugrul Purnak³

Affiliations

Affiliations

¹ Department of Gastroenterology, Diyarbakir Health Science University EAH, Diyarbakir.
² Department of Gastroenterology, Numune Research and Education Hospital.
³ Department of Gastroenterology, Hacettepe University, Ankara, Turkey.

PMID: 29509605
DOI: 10.1097/MEG.0000000000001077

Comment

Second-line immunosuppressants for autoimmune hepatitis

Cumali Efe et al. Eur J Gastroenterol Hepatol. 2018 Apr.

. 2018 Apr;30(4):490-491.

doi: 10.1097/MEG.0000000000001077.

Authors

Cumali Efe¹, Ersan Ozaslan², Tugrul Purnak³

Affiliations

¹ Department of Gastroenterology, Diyarbakir Health Science University EAH, Diyarbakir.
² Department of Gastroenterology, Numune Research and Education Hospital.
³ Department of Gastroenterology, Hacettepe University, Ankara, Turkey.

PMID: 29509605
DOI: 10.1097/MEG.0000000000001077

No abstract available

PubMed Disclaimer

Comment on

A systematic review and meta-analysis of second-line immunosuppressants for autoimmune hepatitis treatment.
De Lemos-Bonotto M, Valle-Tovo C, Costabeber AM, Mattos AA, Azeredo-da-Silva ALF. De Lemos-Bonotto M, et al. Eur J Gastroenterol Hepatol. 2018 Feb;30(2):212-216. doi: 10.1097/MEG.0000000000001019. Eur J Gastroenterol Hepatol. 2018. PMID: 29227329

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wolters Kluwer
Other Literature Sources
- scite Smart Citations